# Chai Discovery Raises $400M Series C for AI Drug Discovery

> Chai Discovery has raised a $400 million Series C that values the AI drug-design startup at $3.8 billion, announced July 14 and led by Index Ventures with Kleiner Perkins, Sequoia, and Dimension. The valuation is roughly triple where the company stood just seven months earlier, a jump that captures how hot AI biotech has become. Founded in 2024 by a team drawn from DeepMind and academia, Chai builds AI models for molecular design and drug discovery, the kind of work that aims to compress years of pharmaceutical trial and error into faster computational search. The raise gives it the capital to scale that effort at a moment when investors are betting heavily on AI reaching into the life sciences. The pace of the markup is its own story. A near-tripling in seven months says less about any single result than about how much money is flowing toward the idea that AI can meaningfully accelerate how new drugs are found.

_Section: [AI Funding Tracker](https://www.wortins.com/funding) · Source: The Next Web · Published Wednesday, July 22, 2026_

## Wortins' read

Chai Discovery has raised a $400 million Series C that values the AI drug-design startup at $3.8 billion, announced July 14 and led by Index Ventures with Kleiner Perkins, Sequoia, and Dimension. The valuation is roughly triple where the company stood just seven months earlier, a jump that captures how hot AI biotech has become. Founded in 2024 by a team drawn from DeepMind and academia, Chai builds AI models for molecular design and drug discovery, the kind of work that aims to compress years of pharmaceutical trial and error into faster computational search. The raise gives it the capital to scale that effort at a moment when investors are betting heavily on AI reaching into the life sciences. The pace of the markup is its own story. A near-tripling in seven months says less about any single result than about how much money is flowing toward the idea that AI can meaningfully accelerate how new drugs are found.

## Source

[Read the full story at The Next Web](https://thenextweb.com/news/chai-discovery-400m-series-c-ai-drug-discovery)

## Related coverage

- [Nvidia and Palantir team up to run supply chains with AI, starting with Nvidia's own million-part operation](https://www.wortins.com/story/nvidia-and-palantir-team-up-to-run-supply-chains-with-ai-sta-4206093d) — [The Decoder](https://the-decoder.com/nvidia-and-palantir-team-up-to-run-supply-chains-with-ai-starting-with-nvidias-own-million-part-operation/)
- [Researchers used AI to build a WeChat worm that spreads through phone calls](https://www.wortins.com/story/researchers-used-ai-to-build-a-wechat-worm-that-spreads-thro-8bf3f469) — [The Next Web](https://thenextweb.com/news/wechat-worm-ai-calif-tencent-zero-click)
- [STAT+: Can AI fix the emergency room?](https://www.wortins.com/story/stat-can-ai-fix-the-emergency-room-a71d00ee) — [STAT](https://www.statnews.com/2026/09/09/scribe-emergency-room-fix-health-care-ai-prognosis/?utm_campaign=rss)
- [Inception launches Mercury 2.5 at 1,107 tokens per second](https://www.wortins.com/story/inception-launches-mercury-2-5-at-1-107-tokens-per-second-7999ed1b) — [TestingCatalog](https://www.testingcatalog.com/inception-launches-mercury-2-5-at-1-107-tokens-per-second/)
- [A look at why the oft-discussed predictions that AI will deliver double-digit GDP growth in advanced economies are extremely unlikely over the next 10-15 years (Ghosts of Electricity)](https://www.wortins.com/story/a-look-at-why-the-oft-discussed-predictions-that-ai-will-del-6241fa38) — [Techmeme](https://www.techmeme.com/260910/p10#a260910p10)
- [Top AI spenders cut per-employee costs by nearly 10 percent in August](https://www.wortins.com/story/top-ai-spenders-cut-per-employee-costs-by-nearly-10-percent--b31ffb0b) — [The Decoder](https://the-decoder.com/top-ai-spenders-cut-per-employee-costs-by-nearly-10-percent-in-august/)

---

_Curated and written by [Wortins](https://www.wortins.com) — The daily AI briefing. Every story links to its original source; the "Wortins read" on each is our own original analysis. [About Wortins & our editorial approach](https://www.wortins.com/about)._